Skip to main content

Lantern Wealth Advisors, LLC

SEC CIK
0001950218
Latest filing
Jul 28, 2026

VRTX holding history

Vertex Pharmaceuticals Inc in every 13F filed by Lantern Wealth Advisors, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

VRTX overviewAll 13F holders of VRTXFull Q2 2026 holdings

Shares (Q2 2026)
1,250
Value
$620.9K
% of portfolio
0.3%
Quarters held
9
Since Q1 2024
Holdings of VRTX by Lantern Wealth Advisors, LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20261,250$620.9K0.3%−300−19.4%ReducedHolders
Q1 20261,550$692.1K0.4%00.0%UnchangedHolders
Q4 20251,550$702.7K0.4%00.0%UnchangedHolders
Q3 20251,550$607.0K0.3%00.0%UnchangedHolders
Q2 20251,550$690.1K0.4%–No prior filingHolders
Q1 2025––––Not filedHolders
Q4 20241,550$624.2K0.4%+650+72.2%AddedHolders
Q3 2024900$418.6K0.3%00.0%UnchangedHolders
Q2 2024900$421.8K0.3%00.0%UnchangedHolders
Q1 2024900$376.2K0.3%+900NewHolders